drugset / Trial / NCT06577909
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, randomized, open-label, multicenter clinical trial study to compare the efficacy and safety of prednisone plus IVIg to prednisone monotherapy in the treatment of immune thrombocytopenia (ITP) in pregnancy.
Timeline
- Start
- 2023-10-19
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 400 mg/kg | Intravenous |
| Subject | Prednisone | Other / unclassified | 5 mg | Oral |
| Subject | Prednisone | Other / unclassified | 10 mg | Oral |